MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 111 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 4.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $312,380 | -36.8% | 2,139 | 0.0% | 0.52% | -4.0% |
Q2 2023 | $494,109 | -29.5% | 2,139 | -26.0% | 0.54% | -36.7% |
Q1 2023 | $700,616 | -1.6% | 2,892 | +17.8% | 0.86% | +23.6% |
Q4 2022 | $712,274 | +25.0% | 2,454 | -69.9% | 0.70% | +22.5% |
Q3 2022 | $570,000 | -2.4% | 8,162 | 0.0% | 0.57% | +5.2% |
Q2 2022 | $584,000 | -52.6% | 8,162 | -35.0% | 0.54% | -39.7% |
Q1 2022 | $1,232,000 | -20.3% | 12,556 | -31.2% | 0.90% | -16.0% |
Q4 2021 | $1,546,000 | +64.5% | 18,249 | +55.0% | 1.07% | +186.1% |
Q3 2021 | $940,000 | -18.0% | 11,775 | 0.0% | 0.37% | +0.8% |
Q2 2021 | $1,147,000 | -70.3% | 11,775 | -64.4% | 0.37% | -72.7% |
Q1 2021 | $3,866,000 | +42.8% | 33,048 | +35.7% | 1.35% | +103.6% |
Q4 2020 | $2,707,000 | -1.8% | 24,351 | 0.0% | 0.66% | -27.8% |
Q2 2020 | $2,758,000 | +69.6% | 24,351 | 0.0% | 0.92% | +34.8% |
Q1 2020 | $1,626,000 | -23.6% | 24,351 | +4.3% | 0.68% | -8.8% |
Q4 2019 | $2,128,000 | +21.4% | 23,355 | +13.4% | 0.75% | +12.1% |
Q3 2019 | $1,753,000 | -3.8% | 20,593 | +13.5% | 0.67% | 0.0% |
Q2 2019 | $1,823,000 | +27.8% | 18,148 | +32.9% | 0.67% | +5.7% |
Q1 2019 | $1,427,000 | 0.0% | 13,659 | 0.0% | 0.63% | +3.6% |
Q4 2018 | $1,427,000 | -6.7% | 13,659 | +89.7% | 0.61% | +16.4% |
Q3 2018 | $1,529,000 | -16.7% | 7,201 | +9.0% | 0.52% | -22.8% |
Q2 2018 | $1,836,000 | +40.5% | 6,605 | -41.0% | 0.68% | +26.4% |
Q1 2018 | $1,307,000 | – | 11,195 | – | 0.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |